Valued at USD 1.33 billion in 2024, the global gastric cancer diagnostics market is expected to grow at a CAGR of 7.7% over the next decade, driven by advancements in diagnostic modalities and shifting clinical paradigms toward precision medicine. The market is highly segmented based on product type, application, and end-user, with each segment exhibiting distinct growth trajectories influenced...
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek